CClinicalTrials.gg
CompletedNCT00976547Updated Sep 14, 2009

Correlation Analysis of Hearing Thresholds, Validated Questionnaires and Psychoacoustic Measurements in Tinnitus Patients

An observational study in Tinnitus, Hearing Loss and Depression, sponsored by Faculdade de Medicina de Valenca. Completed at 2 sites in Brazil. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2009-09-14.

Sponsored by Faculdade de Medicina de Valenca · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
48
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Objective: To evaluate the correlation between audiometric thresholds, pitch matching (PM), minimum masking level (MML), Tinnitus Handicap Inventory (THI) and the Beck Depression Inventory (BDI) in tinnitus patients.

Subjects: 48 patients with tinnitus as the main complaint from OTOSUL, Otorrinolaringologia Sul-Fluminense, Volta Redonda, RJ, Brasil and Centro de Tratamento e Pesquisa em Zumbido, Belo Horizonte, MG, Brasil.

Method: Subjects performed tonal audiometry, Pitch Matching (PM) and Minimum Masking Level (MML) for tinnitus. They also fulfilled the Tinnitus Handicap Inventory (THI) and Beck Depression Inventory (BDI). Data was statistically compared for correlation between audiometric thresholds, psycho-acoustic measures and questionnaires.

02

Conditions studied

  • Tinnitus
  • Hearing Loss
  • Depression

Keywords

  • tinnitus
  • depression
  • audiometry
  • measurement
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 48 is below the median of 87 across 270 observational studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Faculdade de Medicina de Valenca is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

48 tinnitus patients sensorineural hearing losses

Inclusion criteria

  • tinnitus for more than 6 months
  • sensorineural hearing loss
  • normal otoscopy

Exclusion criteria

Exclusion Criteria:

  • conductive or mixed hearing losses
  • A-r, A-d, B and C tympanograms
  • tinnitus treatment in the last 6 months
  • pregnant woman
  • Vestibular Schwannoma
05

Study design

Time perspective
Prospective
Enrollment
48 participants (actual)

Groups and cohorts

  • Tinnitus patients

    Group of 48 tinnitus patients

06

Study locations

2 sites
  • Centro de Diagnóstico e Tratamento do Zumbido
    Belo Horizonte, MG, Brazil
  • OTOSUL,Otorrinolaringologia Sul-Fluminense
    Volta Redonda, RJ 27255-650, Brazil
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00976547
Lead sponsor
Faculdade de Medicina de Valenca
First posted
Sep 14, 2009
Start date
Jan 2009
Primary completion
May 2009
Completion
Jun 2009
Last update
Sep 14, 2009

Study contacts

Ricardo R Figueiredo, MDMSc
study chair · OTOSUL, Faculdade de Medicina de Valença

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion